Mitchell Brin

Mitchell Brin is currently the Senior Vice President of R&D and Chief Scientific Officer for BOTOX & Neurotoxins at AbbVie, a position held since 2020. Prior to joining AbbVie, they served as Senior Vice President of Global Drug Development & Chief Scientific Officer at Allergan from 2018 to 2020. Brin has extensive academic experience, including a Professorship in Neurology at the University of California, Irvine since 2002 and an Assistant Professorship at Columbia University Medical Center from 1986 to 1994. They also held the position of Bachmann-Strauss Professor of Neurology at Mount Sinai School of Medicine from 1998 to 2001. Brin earned a Doctor of Medicine from Columbia University College of Physicians and Surgeons in 1979, following a Bachelor's degree in Biology from the University of Pennsylvania.